◼ Archived
Business
🔮 Newsylist predicts: still trending tomorrow low confidence — graded ✗ wrong
Amylyx Stock Surges 55% After GLP-1 Blocker Hits All Trial Goals
4sources
6articles
3velocity
+0%since first seen
34d agofirst detected
Text:
🤖 AI Dossier
Who reported it (6)
-
-
-
-
-
-
Amylyx readies approval push after GLP-1 inhibitor halves blood sugar crashes in ph. 3 win Fierce Biotech · 34d ago broke it first
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📊 AUDIENCE & LONGEVITY PULSE
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.
From around our network
Related trends
▲ Peaking
Business
Shopify to Use Meta’s Muse for Agentic Checkout
↓ Cooling
Business
Alibaba plans AI model with 5 trillion to 10 trillion parameters, unveils new chip
↑ Rising
Business
GameStop CEO Ryan Cohen Buys Another $26 Million of GME Stock
▲ Peaking
Business
Satellite industry grapples with the end of Falcon 9
↑ Rising
Business
Sept. 19 Powerball results: 31 players come heartbreakingly close to winning the $298M jackpot
↓ Cooling
Business
🔮 holds